Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 12:21 AM ET

Company Overview of The Wistar Institute

Company Overview

The Wistar Institute is an educational institution.

3601 Spruce Street

Philadelphia, PA 19104

United States

Key Executives for The Wistar Institute

President and Chief Executive Officer
Director of Communications
Chief Scientific Officer and Director of Cancer Center
Compensation as of Fiscal Year 2015.

The Wistar Institute Key Developments

OncoCyte Corporation and The Wistar Institute Enter into Global Licensing Agreement

OncoCyte Corporation and The Wistar Institute have entered into a definitive global licensing agreement for a simple, non-invasive, blood test to aid physicians in the early detection of lung cancer. The agreement provides OncoCyte the exclusive rights to commercialize this lung cancer diagnostic test. Since 2013, OncoCyte and Wistar have been collaborating on product development of the lung cancer diagnostic test. In 2015, positive interim clinical results demonstrating the high level of observed sensitivity and specificity in the assayed samples of a prototype blood test for lung cancer were presented at the American Thoracic Society International Conference. Now, both parties are finalizing this assay, which is intended to serve as a confirmatory test for patients who are at risk for lung cancer (based on a patient’s positive or suspicious results identified by low dose computed tomography (LDCT) screening). If successful scientific and technical results are achieved, OncoCyte will proceed to the test’s final validation with the goal of completing work in 2016 to enable its commercial launch.

The Wistar Institute Presents at IMPACT 2015 Capital Conference, Nov-04-2015 03:30 PM

The Wistar Institute Presents at IMPACT 2015 Capital Conference, Nov-04-2015 03:30 PM. Venue: The Ritz-Carlton Hotel, Philadelphia, Pennsylvania, United States. Speakers: Heather Steinman, VP for BD and Executive Director, Technology Transfer.

The Wistar Institute and OncoCyte Corporation Expand Collaboration to Develop Lung Cancer Diagnostic Test

The Wistar Institute and OncoCyte Corporation have expanded their collaboration to develop a non-invasive, blood-based test designed to aid physicians in the early detection of lung cancer. In October 2013, OncoCyte entered into a Sponsored Research Agreement with The Wistar Institute to develop and test potential lung cancer biomarkers identified by Dr. Louise Showe, Ph.D., professor in Wistar's Molecular and Cellular Oncogenesis Program. Under the new expanded agreement, OncoCyte and Wistar will continue their collaboration with the goal of developing a highly sensitive and specific diagnostic test for the early detection of lung cancer. Critical to the success of the next phase of the R&D program will be the analysis of an expanded patient sample set, the transition of sample analysis to a platform capable of commercial scale operations, confirmation of mRNA and miRNA expression, and completion of diagnostic test verification activities. Dependent on achieving successful scientific and technical results at this stage of development, OncoCyte and Wistar will proceed to final validation of the test with the goal of completing that work in 2016 to enable OncoCyte to commercially launch the lung diagnostic test. OncoCyte has exercised options to obtain exclusive licenses to any inventions, discoveries or technology developed in the course of the collaborative research and expects to finalize definitive license agreements with Wistar in the near future.

Similar Private Companies By Industry

Company Name Region
INB Life Insurance Co. United States
GTC Insurance Agency, Inc. United States
Prentice Family Partnership United States
Greenback Asphalt Co. Inc. United States
Adzone Research Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Wistar Institute, please visit www.wistar.org/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.